Amerikanische Gesellschaft für Hirudotherapie

Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry

Research article published in Analytical chemistry (2013)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)ArzneimittelentwicklungSicherheit & InfektionskontrolleLi G et al. · Analytical chemistry, 2013

Abstract

Heparin is a critically important anticoagulant drug that was contaminated with a persulfonated polysaccharide in 2008, resulting in a number of severe adverse reactions, some leading to death. Controversy remains as to the precise composition of the 2008 contaminant, and new information suggests that heparin may now be subject to adulteration with a new, difficult to detect, contaminant, N-sulfo oversulfated chondroitin sulfate. This study synthesizes this new potential contaminant and describes the use of radical depolymerization followed by liquid chromatography-mass spectrometry to detect N-sulfo oversulfated chondroitin sulfate and to confirm the structure of the 2008 contaminant as oversulfated chondroitin sulfate and not oversulfated heparan sulfate.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsChondroitin SulfatesChromatography, LiquidDrug ContaminationHeparinMass SpectrometryPolymerizationSwine

Zusammenfassung

Heparin is a critically important anticoagulant drug that was contaminated with a persulfonated polysaccharide in 2008, resulting in a number of severe adverse reactions, some leading to death.

Warum dies für die Hirudotherapie relevant ist

This study describes an analytical method using radical depolymerization and liquid chromatography-mass spectrometry to detect newly discovered potential contaminants, such as N-sulfo oversulfated chondroitin sulfate, within the anticoagulant drug heparin. The research is strictly focused on pharmaceutical quality control, safeguarding public health by confirming the precise composition of contaminated samples and identifying difficult-to-detect impurities in conventional mammalian-derived drugs. This work does not involve leeches, hirudotherapy, or the leech secretome in any capacity. Thus, its relevance to the American Society of Hirudotherapy is entirely absent, serving only as an indirect reference to the analytical surveillance of pharmaceutical anticoagulants.

Zitation

Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry

Li G et al. · Analytical chemistry, 2013

DOI

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Drug PipelineDrug DevelopmentDirect Thrombin InhibitorsSafety ProtocolsAeromonas ManagementAnticoagulation CompoundsHemostasisHirudinOtolaryngology

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.